Showing results (401-410 of 424) with videos related to
Sort By:
Pageof 43
Nature Communications|September 28, 2021
Testing CPT symmetry in ortho-positronium decays with positronium annihilation tomographyP Moskal, A Gajos, M Mohammed, et al.Cancer Research|February 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular CarcinomaRenée L Flaherty, Flavia Hughes, George Sflomos, et al.Nature Genetics|July 31, 2023
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress responsePhilip Bland, Harry Saville, Patty T Wai, et al.Nature Communications|July 25, 2020
Mutations in FAM50A suggest that Armfield XLID syndrome is a spliceosomopathyYu-Ri Lee, Kamal Khan, Kim Armfield-Uhas, et al.Cancer Discovery|November 5, 2021
DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial InhibitionElisa Izquierdo, Diana M Carvalho, Alan Mackay, et al.Cancer Research|July 8, 2017
Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin ActivationTushar D Bhagat, Si Chen, Matthias Bartenstein, et al.Nature Medicine|March 8, 2022
High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disasterSakshi Jasra, Orsi Giricz, Rachel Zeig-Owens, et al.Nature Communications|January 20, 2026
Community benchmarking and evaluation of human unannotated microprotein detection by mass spectrometry based proteomicsAaron Wacholder, Eric W Deutsch, Leron W Kok, et al.Biorxiv : the Preprint Server for Biology|March 3, 2025
Detection of human unannotated microproteins by mass spectrometry-based proteomics: a community assessmentAaron Wacholder, Eric W Deutsch, Leron W Kok, et al.Cancer Research|January 29, 2021
3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast CancerBarrie Peck, Philip Bland, Ioanna Mavrommati, et al.Pageof 43